Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Neoplasm Metastasis 5Myofibroma 5Hemorrhage 4Leiomyoma 3Blood Loss, Surgical 3Uterine Cervical Neoplasms 1Myoma 1Diabetes Insipidus 1

Interventions

telapristone acetate 18ulipristal acetate 17Uterine Myomectomy 13vilaprisan 12Leuprolide 11relugolix 9estradiol, norethindrone drug combination 9asoprisnil 9elagolix 7Uterine Artery Embolization 7Mifepristone 7Estradiol 7Bupivacaine 7ulipristal 6Tranexamic Acid 6Saline Solution 5Norethindrone Acetate 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Letrozole 4Hysterectomy 4Vitamin B 6 3Sugars 3Misoprostol 3Lidocaine 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Leiomyoma × Misoprostol × Clear all
NCT02209545 2023-09-07

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Northwestern University

Phase 4 Terminated
47 enrolled 4 charts

Hemorrhage, Leiomyoma

NCT03509168 2018-04-30

MM

Makerere University

Phase 2/3 Unknown
46 enrolled

Leiomyoma

NCT02061657 2014-08-12

Impact of Misoprostol on Blood Loss In Myomectomy Operations

Ain Shams University

Phase 3 Completed
50 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡